| Financial Year |
March 31 2023 |
| Monetary Funds |
213,550,222.55 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,835,840.78 |
| Accounts Receivable |
3,031,938,024.00 |
| Advances to Suppliers |
72,713,957.49 |
| Other Receivables |
676,283,389.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
158,834.38 |
| Dividend Receivable |
-- |
| Inventories |
160,272,699.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
611,154,886.32 |
| Other Current Assets |
666,481,047.77 |
| Total Current Assets |
5,829,581,212.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,641,896,535.85 |
| Long-term Equity Investment |
95,769,287.53 |
| Investment Properties |
18,040,250.70 |
| Fixed Assetes |
7,033,868,097.65 |
| Under-construction Projects |
1,019,593,096.52 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
316,740,864.94 |
| R&D expenses |
1,216,981.11 |
| Goodwill |
1,318,805.16 |
| Long-Term Deferred and Prepaid Expenses |
719,961,587.98 |
| Deferred Income Tax Assets |
59,358.12 |
| Other Non-Current Assets |
218,948,387.01 |
| Sub-Total of Non-Current Assets |
12,370,797,151.42 |
| Total Assets |
18,200,378,363.52 |
| Short-Term Loans |
4,078,381,060.81 |
| Trading Financial liabilities |
-- |
| Notes Payable |
728,836,890.90 |
| Accounts Payable |
2,418,028,342.52 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
134,531,953.39 |
| Taxes Payable |
7,188,775.21 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
421,462,062.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
491,777,843.98 |
| Other Current Liabilities |
90,419,328.91 |
| Sub-Total of Current Liabilities |
9,096,015,777.44 |
| Long-term Loans |
2,004,450,137.39 |
| Bonds Payable |
280,736,462.71 |
| Long-Term Accounts Payable |
541,523,245.88 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
288,313.63 |
| Other Non-Current Liabilities |
20,735,299.69 |
| Sub-Total of Non-Current Liabilities |
3,209,724,817.74 |
| Total Liabilities |
12,305,740,595.18 |
| Paid-In Capital(Or Share Stock) |
1,207,547,762.00 |
| Capital Surplus |
2,846,643,708.16 |
| Surplus Reserve |
232,679,924.17 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,019,733,928.40 |
| Minority Stockholder's Interest |
561,532,153.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,333,105,614.56 |
| Owner's Equity（Stockholder's Equity） |
5,894,637,768.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,200,378,363.52 |
